What is UroGen Pharma's change in other liabilities?

UroGen Pharma (URGN) reported change in other liabilities of $0 in Q1 2026.

How has UroGen Pharma's change in other liabilities changed year-over-year?

UroGen Pharma's change in other liabilities decreased by 100.0% year-over-year, from $483K to $0.

What is the long-term trend for UroGen Pharma's change in other liabilities?

Over 3 years (2021 to 2025), UroGen Pharma's change in other liabilities has grown at a 62.6% compound annual growth rate (CAGR), from $47K to -$202K.

What does change in other liabilities mean?

Change in miscellaneous liabilities affecting operating cash flow.

UroGen Pharma URGN Change in Other Liabilities

Change in Other Liabilities at other companies

PfizerPFE

-$916.75M-17.7%

Johnson & JohnsonJNJ

-$629M+90.3%

Merck & Co.MRK

$48.75M+498%

CG OncologyCGON

-$329K—

LQD

Liquidia CorporationLQDA

$873K—

Krystal Biotech, Inc.KRYS

$1.44M+169%

Other financials

Income statement

See full

Revenue$51.0M+152%

Gross profit$11.6M—

Operating income-$22.8M—

Net income-$23.6M+46.2%

EPS (diluted)-$1.17—

Balance sheet

See full

Cash & equivalents$110.0M+5.7%

Total debt$197.1M+56.0%

Total equity-$124.3M-167%

Total assets$253.7M+2.5%

Cash flow

See full

Operating cash flow-$45.3M-7.8%

CapEx$54.0K+22.7%

Free cash flow-$45.4M-7.8%

Valuation

See full

Market cap$1.73B+71.7%

Enterprise value$1.81B+80.9%

P/S12.3×+1.3×

Profitability

See full

Gross margin89.7%—

Operating margin-329.7%—

Net margin-94.8%-25.6pp

FCF margin-118.2%+1.3pp

Returns & leverage

See full

Return on equity-211.6%—

Debt / equity4.8×—

Current ratio4.7×-1.0×

Where this comes from

Reported directly by UroGen Pharma in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherCurrentLiabilities.

The official record: UroGen Pharma’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about UroGen Pharma's change in other liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is UroGen Pharma's change in other liabilities?: UroGen Pharma (URGN) reported change in other liabilities of $0 in Q1 2026.
How has UroGen Pharma's change in other liabilities changed year-over-year?: UroGen Pharma's change in other liabilities decreased by 100.0% year-over-year, from $483K to $0.
What is the long-term trend for UroGen Pharma's change in other liabilities?: Over 3 years (2021 to 2025), UroGen Pharma's change in other liabilities has grown at a 62.6% compound annual growth rate (CAGR), from $47K to -$202K.
What does change in other liabilities mean?: Change in miscellaneous liabilities affecting operating cash flow.